Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases

Published:2007-12 Issue:6 Volume:84 Page:1818-1824
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Riquet Marc,Bagan Patrick,Le Pimpec Barthes Françoise,Banu Eugeniu,Scotte Florian,Foucault Christophe,Dujon Antoine,Danel Claire

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference31 articles.

1. Surgical treatment of non-cell lung cancer;Ponn,2005

2. Factors determining survival in resected N2 lung cancer;Riquet;Eur J Cardiothorac Surg,1995

3. Survival of patients with resected N2 non-small cell lung cancer: evidence for a subclassification and implications;Andre;J Clin Oncol,2000

4. Regional lymph node classification for lung cancer staging;Mountain;Chest,1997

5. Direct lymphatic drainage of lung segments to mediastinal nodes;Riquet;J Thorac Cardiovasc Surg,1989

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer;Journal of Cardiothoracic Surgery;2023-06-13

2. Upfront surgery for N2 NSCLC: a large retrospective multicenter cohort study;General Thoracic and Cardiovascular Surgery;2023-05-14

3. Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching method;Oncology Letters;2023-04-05

4. The Significance of Skip Mediastinal Lymph Node Metastasis in the Prognosis of Patients with Resected Non-Small-Cell Lung Carcinoma: Is It Really a Better N2 Disease Subtype?;Annals of Thoracic and Cardiovascular Surgery;2021

5. Resectable IIIA-N2 Non-Small-Cell Lung Cancer (NSCLC): In Search for the Proper Treatment;Cancers;2020-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3